ThinkSabio

$BDSX

$24.40▲ +2.0% YTD

7 SEC 13D/G filings tracked · Last updated Oct 22, 2026

Filing History
News
BDSX ▲ +2.0% - Biodesix, Inc.
CP $24.40▲ +2.0%Oct 22, 2026 · ThinkSabio Blog

$BDSX - Biodesix to Report Third Quarter 2026 Financial Results on November 5, 2026…

News
BDSX ▼ -0.6% - Biodesix, Inc.
CP $23.40▲ -0.6%Oct 19, 2026 · ThinkSabio Blog

$BDSX - American College of Chest Physicians Publishes New Framework for Lung Nodule Programs Recommending Biomarkers for Risk Stratification…

News
BDSX ▲ +0.5% - Biodesix, Inc.
CP $23.66▲ +0.5%Oct 19, 2026 · ThinkSabio Blog

$BDSX - Biodesix Adds Digital Diagnostics to Lung Pipeline, Creating New Growth Platform Combining Blood and Imaging Biomarkers…

News
BDSX ▼ -0.1% - Biodesix, Inc.
CP $25.70▲ -0.1%Oct 13, 2026 · ThinkSabio Blog

$BDSX - Biodesix to Present New Real-World Evidence Supporting Integration of Nodify Lung® Testing into Routine Lung Nodule Care at CHEST 2026…

News
BDSX ▲ +0.2% - Biodesix, Inc.
CP $29.29▲ +0.2%Sep 24, 2026 · ThinkSabio Blog

$BDSX - Biodesix Advances Two Complementary Approaches to Molecular Residual Disease (MRD) Monitoring…

News
BDSX ▲ +1.6% - Biodesix, Inc.
CP $27.40▲ +1.6%Sep 14, 2026 · ThinkSabio Blog

$BDSX - Biodesix Quality and Regulatory Executive, Brianna Phillips, to speak at upcoming RAPS and SOCRA Annual Meetings…

SEC 13D/G
$BDSX SEC Filing Update (18-JUN-2026) | ThinkSabio - Stocks Simplified
$16.81▲ 163.48%Jun 18, 2026 · ThinkSabio Blog

SEC Filing Update: #BDSX : $16.81 Sector: Healthcare | YTD: 🔼+ 163.48% The SEC disclosed Today (18-JUN-2026) that SOLEUS CAPITAL MASTER FUND, L.P. has…